연구성과로 돌아가기

2024 연구성과별 연구자 정보 (729 / 2344)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia Song, Yeong-Wook Song, YW 7 Seoul Natl Univ, Inst Human Environm Interface Biol, Med Res Ctr, Seoul, South Korea 0000-0002-5384-3437 Song, Yeong Wook scbae@hanyang.ac.kr;
Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia Kang, Young Mo Kang, YM 8 Kyungpook Natl Univ Hosp, Dept Internal Med, Div Rheumatol, Daegu, South Korea scbae@hanyang.ac.kr;
Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia Cho, Chul-Soo Cho, CS 9 Catholic Univ Korea, Yeouido St Marys Hosp, Dept Internal Med, Div Rheumatol, Seoul, South Korea scbae@hanyang.ac.kr;
Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia Park, Won Park, W 10 In Ha Univ, Sch Med, Med Rheumatol, Inchon, South Korea 0000-0002-0004-8034 park, won scbae@hanyang.ac.kr;
Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia Kwok, Seung-Ki Kwok, SK 11 Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Rheumatol, Seoul, South Korea scbae@hanyang.ac.kr;
Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia Lee, Seung-Geun Lee, SG 12 Pusan Natl Univ Hosp, Dept Internal Med, Div Rheumatol, Busan, South Korea scbae@hanyang.ac.kr;
Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia Chung, Won Tae Chung, WT 13 Dong A Univ Hosp, Dept Internal Med, Div Rheumatol, Busan, South Korea scbae@hanyang.ac.kr;
Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia Bae, Sang-Cheol Bae, SC 14 교신저자 Hanyang Univ, Hosp Rheumat Dis, Inst Rheumatol, Dept Rheumatol, Seoul, South Korea P-2051-2015 Bae, Sang-Cheol scbae@hanyang.ac.kr;
Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia Bae, Sang-Cheol Bae, SC 14 교신저자 Hanyang Univ, Inst Biosci & Biotechnol, Seoul, South Korea P-2051-2015 Bae, Sang-Cheol scbae@hanyang.ac.kr;
Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia Bae, Sang-Cheol Bae, SC 14 교신저자 Hanyang Univ, Hosp Rheumat Dis, Seoul 04763, South Korea P-2051-2015 Bae, Sang-Cheol scbae@hanyang.ac.kr;
Efficacy and Safety of Lurasidone vs. Quetiapine XR in Acutely Psychotic Patients With Schizophrenia in Korea: A Randomized, Double-Blind, Active-Controlled Trial Kim, Se Hyun Kim, SH 1 Seoul Natl Univ Hosp, Dept Psychiat, Seoul, South Korea 0000-0001-7078-2835 Kim, Se Hyun hyjung@snu.ac.kr;
Efficacy and Safety of Lurasidone vs. Quetiapine XR in Acutely Psychotic Patients With Schizophrenia in Korea: A Randomized, Double-Blind, Active-Controlled Trial Kim, Se Hyun Kim, SH 1 Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea 0000-0001-7078-2835 Kim, Se Hyun hyjung@snu.ac.kr;
Efficacy and Safety of Lurasidone vs. Quetiapine XR in Acutely Psychotic Patients With Schizophrenia in Korea: A Randomized, Double-Blind, Active-Controlled Trial Jung, Do-Un Jung, DU 2 Inje Univ, Busan Paik Hosp, Coll Med, Dept Psychiat, Busan, South Korea hyjung@snu.ac.kr;
Efficacy and Safety of Lurasidone vs. Quetiapine XR in Acutely Psychotic Patients With Schizophrenia in Korea: A Randomized, Double-Blind, Active-Controlled Trial Kim, Do Hoon Kim, D 3 Hallym Univ, Chuncheon Sacred Heart Hosp, Coll Med, Dept Psychiat, Chunchon, South Korea KOD-4275-2024 KOO, BON HOON 0000-0002-6588-9221 Kim, Do Hoon hyjung@snu.ac.kr;
Efficacy and Safety of Lurasidone vs. Quetiapine XR in Acutely Psychotic Patients With Schizophrenia in Korea: A Randomized, Double-Blind, Active-Controlled Trial Kim, Do Hoon Kim, D 3 Hallym Univ, Coll Med, Mind Neuromodulat Lab, Chunchon, South Korea KOD-4275-2024 KOO, BON HOON 0000-0002-6588-9221 Kim, Do Hoon hyjung@snu.ac.kr;
페이지 이동: